HTG Molecular Diagnostics Stock News

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on CareDx (CDNA), with a price target of $40.00. The company's shares

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on CareDx (CDNA – Research Report),

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alimera (ALIM) and Seattle Genetics (SGEN) with bullish

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alimera (ALIM

We highlight main points from Roche Q1 conference call and summarize key takeaways for investors. Pharma is showing resilience in the face of intensive biosimil

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Selecta Biosciences (SELB), CytoDyn (CYDY) and Sutro

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on CareDx (CDNA) today and set a price target of $43.00. The company's shares closed last Thursday

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on CareDx ( CDNA – Research Report ) today and set a price target of $43.00 . The company’s shares closed last Thursday at $24.08. According

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunomedics (IMMU), Interpace Diagnostics Group (IDXG) and

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunomedics ( IMMU – Research Report ), Interpace Diagnostics Group ( IDXG – Research Report ) and

Some blood tests being marketed to tell people if they have had the new coronavirus are a "disaster", Roche Chief Executive Severin Schwan said on Wednesday as he prepares to launch the drugmaker's ow

La croissance a été alimentée par la principale division Pharmaceuticals, dont les revenus ont progressé de 3% à 12,26 milliards. L'action a clôturé en nette hausse.

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rockwell Med (RMTI) and Motus Gi Holdings (MOTS) with

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rockwell Med ( RMTI – Research Report ) and Motus Gi Holdings ( MOTS – Research Report ) with bulli

The global autoimmune disease diagnosis market size is projected to register a CAGR of 8.9% during the forecast period.